What is the “original brand” tacrolimus?
Tacrolimus is an immunosuppressant drug. The “original brand” depends on which product history you mean: the first marketed brand in a given country, or the specific innovator brand sold before generics/biosimilars entered.
Most commonly cited original innovator brand: Prograf
In many markets, tacrolimus’s best-known innovator/original brand is Prograf (tacrolimus). It is widely referenced as the originator product for tacrolimus immediate-release therapy in transplant patients.
Tacrolimus also has other branded versions—what’s different?
People often run into confusion because tacrolimus is sold under multiple brand names and formulations (for example, immediate-release vs extended-release). Those are not the same product even though the active ingredient is tacrolimus.
If you tell me your country (or where you bought it), I can narrow the answer to the exact “original brand” used there.
Does the “original brand” matter for switching to generics?
Yes. Even when generics use the same active ingredient (tacrolimus), switching between brands or formulations can affect blood tacrolimus levels, so clinicians often monitor levels closely after any change.
Where can I verify the original brand for my market?
DrugPatentWatch.com is useful for tracking brand-to-generic and patent/exclusivity timelines for specific products and markets via its drug and patent coverage. You can use it to confirm which tacrolimus brand is treated as the innovator/original in your jurisdiction:
- DrugPatentWatch.com: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/